Pharmaceutical
| Wed 22 Apr 2026
Geneva, April 23 -- Hoffmann La Roche and Hoffmann La Roche have filed a patent application for TREM2 Agonists. This invention was developed by Charpentier Julie, Di Francesco Maria Emilia, Zeidan Nicolas, O'hara Fionn Susannah, Galley Guido, Gobbi Luca Claudio, Guba Wolfgang, Berchtold Stefan, Caramenti Paola and Imhoff Maria-p..